Vice President, Business Operations at KeifeRx - McLean, VA, US
Chief Executive Officer
Contact Chris Hoyt
Clinical Trial Associate
Contact Kaylah Fernandez
KeifeRx is an emerging clinical-stage biopharmaceutical company developing novel and optimized, low dose, orally delivered tyrosine kinase inhibitors (TKIs) for the treatment of multiple, high-need neurodegenerative and immune diseases.